Recently, TTC39A-AS1 has been revealed to be a critical regulator in the tumorigenicity of patients with breast cancer, where a high level of TTC39A-AS1 correlates with a shorter overall survival. The gene discussed is TTC39A; the disease is breast carcinoma.